Ειδήσεις: PHARMACEUTICAL STOCK | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

24/03 19:13 defenseworld.net

Assenagon Asset Management S.A. Has $377.58 Million Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX

Vertex Pharmaceuticals Assenagon Asset Management Q4 holdings institutional investor pharmaceutical stocks SEC filing

20/03 07:36 defenseworld.net

Jefferies Financial Group Upgrades Silence Therapeutics (NASDAQ:SLN) to Strong-Buy

Silence Therapeutics Jefferies Strong‑Buy analyst ratings target price pharmaceutical stock

19/03 14:28 defenseworld.net

110,064 Shares in Eli Lilly and Company $LLY Bought by CIBC Bancorp USA Inc.

Eli Lilly CIBC Bancorp hedge fund activity Q3 acquisition Q4 stake changes pharmaceutical stocks

19/03 07:58 defenseworld.net

Eli Lilly and Company (NYSE:LLY) Trading Down 1.4% After Analyst Downgrade

Eli Lilly HSBC downgrade price target share price trading volume pharmaceutical stocks

18/03 17:50 investing.com

HSBC’s Pharma Stocks that Offer Value & Growth at a Reasonable Price

Pharmaceutical stocks HSBC Value investing Growth prospects Healthcare sector Equity analysis

18/03 09:06 defenseworld.net

Eupraxia Pharmaceuticals (NASDAQ:EPRX) Given New $11.00 Price Target at HC Wainwright

Eupraxia EPRX analyst rating price target pharmaceutical stock buy

18/03 09:06 defenseworld.net

Eupraxia Pharmaceuticals (NASDAQ:EPRX) Given New $11.00 Price Target at HC Wainwright

Eupraxia EPRX analyst rating price target pharmaceutical stock buy

Loading...